An antivector vaccine protects against a lethal vector-borne pathogen
2006

A Vaccine Against Ticks Protects Mice from Tick-Borne Virus

Sample size: 80 publication 10 minutes Evidence: high

Author Information

Author(s): Labuda Milan, Trimnell Adama R, Ličková Martina, Kazimírová Mária, Davies Gillian M, Lissina Olga, Hails Rosie S, Nuttall Patricia A

Primary Institution: Institute of Zoology, Slovak Academy of Sciences

Hypothesis

Can a vaccine targeting tick proteins protect against tick-borne encephalitis virus (TBEV) in mice?

Conclusion

The anti-tick vaccine derived from tick cement protein protects mice from lethal TBEV infection transmitted by ticks.

Supporting Evidence

  • Immunization with the 64TRP vaccine resulted in significantly more mice surviving compared to controls.
  • Control mice developed fatal encephalitis after exposure to infected ticks.
  • The 64TRP vaccine showed better transmission-blocking effects than a commercial antiviral vaccine.
  • Histological analysis revealed a strong immune response in the skin of vaccinated mice.

Takeaway

Researchers created a vaccine from tick glue that helps protect mice from getting sick when bitten by infected ticks.

Methodology

Mice were immunized with a tick cement protein vaccine and then exposed to TBEV-infected ticks to evaluate protection and transmission.

Limitations

The study did not assess the effects of vaccination on tick feeding and survival.

Participant Demographics

Balb/c mice were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.ppat.0020027

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication